Article Information
History
- July 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Kanan T. Desai1,*,
- Karla Alfaro2,
- Laura Mendoza3,
- Matthew Faron4,
- Brian Mesich4,
- Mauricio Maza2,
- Rhina Dominguez5,
- Adriana Valenzuela3,
- Chyntia DÍaz Acosta3,
- Magaly MartÍnez3,
- Juan C. Felix4,
- Rachel Masch2,6,
- Sofia Gabrilovich7,
- Michael Plump7,
- Akiva P. Novetsky7,8,
- Mark H. Einstein7,8,
- Nataki C. Douglas7,
- Miriam Cremer2,9 and
- Nicolas Wentzensen1
- 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA
- 2Basic Health International, Pittsburgh, USA
- 3Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, San Lorenzo, Paraguay
- 4Medical College of Wisconsin, Milwaukee, USA
- 5Research Unit, El Salvador National Institute of Health (INS), El Salvador
- 6The Mount Sinai Hospital, New York, USA
- 7Rutgers New Jersey Medical School, Newark, USA
- 8Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
- 9Cleveland Clinic Lerner College of Medicine, Clevland, USA
- ↵*Corresponding author
Kanan T. Desai, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, USA, Email: kanan.desai{at}nih.gov
Posted July 06, 2021.
Multi-site clinical validation of Isothermal Amplification based SARS-COV-2 detection assays using different sampling strategies
